Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endoplant is a French medical technology company specializing in the development of innovative dental implant solutions for patients suffering from severe bone atrophy. The company's flagship technology involves 3D-printed, custom-made sub-periosteal implants designed to provide a stable foundation for dental prosthetics without the need for extensive bone grafting. By utilizing advanced digital imaging and additive manufacturing, Endoplant offers a minimally invasive alternative for complex oral rehabilitations. Their approach significantly reduces treatment time and improves patient outcomes in cases where traditional endosseous implants are not feasible. The company operates with a digital-first workflow, integrating CAD/CAM processes to ensure high precision and biocompatibility for each patient-specific device.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endoplant.